Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Depression, Hypoaesthesia, Paraesthesia, Speech disorder
Clinical narrative: received half a dose and waited 30 minutes to receive the other half; depression; anxiety; Vaginal bleeding; some numbness and tingling around her face, mouth, and tongue. Her mouth and jawline were numb; some numbness and tingling around her face, mouth, and tongue. Her mouth and jawline were numb; she was talking weird; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 22 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 18Nov2021 (Batch/Lot number: unknown) at the age of 22 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "allergy" (unspecified if ongoing), notes: Caller was also given allergy medication before she receives her second dose of the vaccine. Concomitant medication(s) included: DEPO PROVERA taken for menstrual cycle management (ongoing). Vaccination history included: Bnt162b2 (Dose 1, Anatomical location: right arm), administration date: 27Oct2021, when the patient was 22 years old, for COVID-19 Immunization, reaction(s): "numbness around her face, mouth, and tongue", "chest pain/pressure", "chest pain/pressure". The following information was reported: WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (non-serious), outcome "unknown", described as "received half a dose and waited 30 minutes to receive the other half"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 2021, outcome "unknown" and all described as "some numbness and tingling around her face, mouth, and tongue. Her mouth and jawline were numb"; SPEECH DISORDER (non-serious) with onset 2021, outcome "unknown", described as "she was talking weird"; VAGINAL HAEMORRHAGE (non-serious) with onset 16Dec2021, outcome "unknown", described as "Vaginal bleeding"; DEPRESSION (non-serious), outcome "unknown", described as "depression"; ANXIETY (non-serious), outcome "unknown", described as "anxiety".Therapeutic measures were taken as a result of depression, anxiety.   Additional Information: patient was taking Zoloft, states when she started taking medication, she started having vaginal bleeding. Calrifies she started the Zoloft on 16Dec2021, states she started bleeding the same day within the same day, states it started maybe a couple hours after she took the medication. Patient stated that she realized that she does not get a menstrual cycle because she is on Depo Provera, states the bleeding was heavy and was like blood clots and  states she discontinued the medication because the bleeding was consistent with her taking the medication, states she took it on 16Dec2021 and bleeding was heavy, the prescription was for once a day, and through the day it would get lighter, and then the next time she took it the bleeding would get heavy again and get lighter through the day. Discontinued around or before 30Dec2021. Clarified they gave both half doses on 18Nov2021. States they had her wait 30 minutes to an hour between the half doses. Had the same treatment of allergy medication after second dose.Zoloft was clarified as sertraline, states it was dispensed in a pharmacy vial. LOT, Expiration Date and manufacturer are unknown. Caller states she has been taking Depo Provera for over 3 years, states she started it when she was overseas somewhere hot and she did not want to have a period in 100 degree weather.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.